Bridging gaps in communicating with patients

Accenture’s Life Sciences Group has a three-year string of polling various parties in healthcare—patients (2015), pharma execs (2016) and now healthcare providers—on key questions around the interaction between patients, the services they need, and the actions taken by pharma companies. […]

Read More

Bye-bye QuintilesIMS; hello IQVIA

A year after the pathbreaking merger of the leading healthcare data company and a leading contract research organization, the combined entity has completed the merging of its business units, at least in terms of branding. Going forward, QuintilesIMS will be […]

Read More

The power of strategic data standardization

The pharmaceutical industry is deluged with data. However, because data is seldom standardized, companies cannot fully tap its potential to substantially reduce the failure rates in drug development. [1] By consciously streamlining and unifying data, drugmakers can improve efficiency throughout […]

Read More

Drug development in rare diseases

In the United States, a rare disease is defined as a condition that affects fewer than 200,000 people, while in the European Union, a disease is defined as rare when it affects fewer than one in 2,000 people. The US […]

Read More

PCI adds to cold chain capacity in Philadelphia

PCI Pharma Services, a contract development and manufacturing organization (CDMO) has announced a 60% expansion of temperature-controlled storage space, from the equivalent of 800 pallet spaces to over 1,300. That 2-8°C storage is primarily to stage commercial production or largescale […]

Read More